Form 8-K - Current report:
SEC Accession No. 0001213900-25-109479
Filing Date
2025-11-13
Accepted
2025-11-12 20:54:31
Documents
14
Period of Report
2025-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0265416-8k_therape.htm   iXBRL 8-K 28925
2 PRESS RELEASE FROM THERAPEUTICSMD, INC., DATED NOVEMBER 12, 2025, ENTITLED "THER ea026541601ex99-1_therape.htm EX-99.1 13245
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4185
  Complete submission text file 0001213900-25-109479.txt   218344

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE txmd-20251112.xsd EX-101.SCH 3032
5 XBRL LABEL FILE txmd-20251112_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE txmd-20251112_pre.xml EX-101.PRE 22370
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0265416-8k_therape_htm.xml XML 3679
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 251475079
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)